Inhibition of p105 processing by NF-κB proteins in transiently transfected cells

Edward Harhaj, S. B. Maggirwar, S. C. Sun

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Regulation of the transcription factor NF-κB involves proteasome-mediated processing of the NF-κB1 p105 precursor protein, which generates the p50 subunit of NF-κB. The processing of p105 occurs constitutively in vivo but can be markedly enhanced by various cellular activation agents, although the underlying regulatory mechanism is not yet clear. In the present study, we demonstrate that signal-mediated induction of p105 processing in human T cells is associated with de novo synthesis of this precursor protein. Transient transfection studies performed in COS7 cells revealed that the newly synthesized p105 protein appears to be more rapidly processed compared to its accumulated form that is already associated with the processed product p50. Interestingly, the processing rate of p105 is markedly inhibited in cells co-transfected with p50 or other NF-κB subunits, including RelA and c-Rel, that physically interact with p105. These findings suggest that the processing of p105 is subject to negative regulation by the various NF-κB subunits. We further demonstrate that p105 undergoes degradation in lipopolysaccharide-stimulated human monocytic cells. However, the inducible degradation of p105 is not coupled with the generation of p50. Together, these studies demonstrate that the processing and inducible degradation of p105 are differentially regulated.

Original languageEnglish (US)
Pages (from-to)2385-2392
Number of pages8
JournalOncogene
Volume12
Issue number11
StatePublished - Jul 5 1996

Fingerprint

Protein Precursors
Proteasome Endopeptidase Complex
Transfection
Lipopolysaccharides
Transcription Factors
T-Lymphocytes
IgA receptor
Proteins

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Harhaj, Edward ; Maggirwar, S. B. ; Sun, S. C. / Inhibition of p105 processing by NF-κB proteins in transiently transfected cells. In: Oncogene. 1996 ; Vol. 12, No. 11. pp. 2385-2392.
@article{dfc98cb01db34914a8787624220353b0,
title = "Inhibition of p105 processing by NF-κB proteins in transiently transfected cells",
abstract = "Regulation of the transcription factor NF-κB involves proteasome-mediated processing of the NF-κB1 p105 precursor protein, which generates the p50 subunit of NF-κB. The processing of p105 occurs constitutively in vivo but can be markedly enhanced by various cellular activation agents, although the underlying regulatory mechanism is not yet clear. In the present study, we demonstrate that signal-mediated induction of p105 processing in human T cells is associated with de novo synthesis of this precursor protein. Transient transfection studies performed in COS7 cells revealed that the newly synthesized p105 protein appears to be more rapidly processed compared to its accumulated form that is already associated with the processed product p50. Interestingly, the processing rate of p105 is markedly inhibited in cells co-transfected with p50 or other NF-κB subunits, including RelA and c-Rel, that physically interact with p105. These findings suggest that the processing of p105 is subject to negative regulation by the various NF-κB subunits. We further demonstrate that p105 undergoes degradation in lipopolysaccharide-stimulated human monocytic cells. However, the inducible degradation of p105 is not coupled with the generation of p50. Together, these studies demonstrate that the processing and inducible degradation of p105 are differentially regulated.",
author = "Edward Harhaj and Maggirwar, {S. B.} and Sun, {S. C.}",
year = "1996",
month = "7",
day = "5",
language = "English (US)",
volume = "12",
pages = "2385--2392",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "11",

}

Harhaj, E, Maggirwar, SB & Sun, SC 1996, 'Inhibition of p105 processing by NF-κB proteins in transiently transfected cells', Oncogene, vol. 12, no. 11, pp. 2385-2392.

Inhibition of p105 processing by NF-κB proteins in transiently transfected cells. / Harhaj, Edward; Maggirwar, S. B.; Sun, S. C.

In: Oncogene, Vol. 12, No. 11, 05.07.1996, p. 2385-2392.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Inhibition of p105 processing by NF-κB proteins in transiently transfected cells

AU - Harhaj, Edward

AU - Maggirwar, S. B.

AU - Sun, S. C.

PY - 1996/7/5

Y1 - 1996/7/5

N2 - Regulation of the transcription factor NF-κB involves proteasome-mediated processing of the NF-κB1 p105 precursor protein, which generates the p50 subunit of NF-κB. The processing of p105 occurs constitutively in vivo but can be markedly enhanced by various cellular activation agents, although the underlying regulatory mechanism is not yet clear. In the present study, we demonstrate that signal-mediated induction of p105 processing in human T cells is associated with de novo synthesis of this precursor protein. Transient transfection studies performed in COS7 cells revealed that the newly synthesized p105 protein appears to be more rapidly processed compared to its accumulated form that is already associated with the processed product p50. Interestingly, the processing rate of p105 is markedly inhibited in cells co-transfected with p50 or other NF-κB subunits, including RelA and c-Rel, that physically interact with p105. These findings suggest that the processing of p105 is subject to negative regulation by the various NF-κB subunits. We further demonstrate that p105 undergoes degradation in lipopolysaccharide-stimulated human monocytic cells. However, the inducible degradation of p105 is not coupled with the generation of p50. Together, these studies demonstrate that the processing and inducible degradation of p105 are differentially regulated.

AB - Regulation of the transcription factor NF-κB involves proteasome-mediated processing of the NF-κB1 p105 precursor protein, which generates the p50 subunit of NF-κB. The processing of p105 occurs constitutively in vivo but can be markedly enhanced by various cellular activation agents, although the underlying regulatory mechanism is not yet clear. In the present study, we demonstrate that signal-mediated induction of p105 processing in human T cells is associated with de novo synthesis of this precursor protein. Transient transfection studies performed in COS7 cells revealed that the newly synthesized p105 protein appears to be more rapidly processed compared to its accumulated form that is already associated with the processed product p50. Interestingly, the processing rate of p105 is markedly inhibited in cells co-transfected with p50 or other NF-κB subunits, including RelA and c-Rel, that physically interact with p105. These findings suggest that the processing of p105 is subject to negative regulation by the various NF-κB subunits. We further demonstrate that p105 undergoes degradation in lipopolysaccharide-stimulated human monocytic cells. However, the inducible degradation of p105 is not coupled with the generation of p50. Together, these studies demonstrate that the processing and inducible degradation of p105 are differentially regulated.

UR - http://www.scopus.com/inward/record.url?scp=0029984104&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029984104&partnerID=8YFLogxK

M3 - Article

C2 - 8649779

AN - SCOPUS:0029984104

VL - 12

SP - 2385

EP - 2392

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 11

ER -